Atlas Trials

Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients

Clinical trial NCT02451462 · WITHDRAWN

Trial details

NCT number
NCT02451462
Sponsor
Stanford University
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hematopoietic Stem Cell TransplantBone Marrow Transplant
Start date
2015-09-01
Primary completion
2017-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.